I agree 100%. People can complain about the $88,000 net profit all they want, but the fact is, they didn't issue shares and they spent a lot more money last year than in the previous couple years...because they had it to spend on Sales/Marketing. Administrative, Legal, etc.
They also reduced the balance on long term note(s).
They are in a better CASH position than they have been in awhile.
NO, naysayers, they aren't rich, they are tiny, tiny Pharma.
They are .0017, and going to be a few hundred percent over that in 2022.
imo, and I know you think the same way Myth.
Mr. Night, if you are reading...you are not off the hook, we need to know a lot more and your shareholders will continue to hold you accountable for the info we need and continue to take exception to your Tweets and PR's if we don't like them. No disrespect. Bring the meat please.
hl shmn Good weekend, gnt extra lime. :)
Market Data 
Markets 
AI
